A multimodal ipsc platform for cystic fibrosis drug testing

HIGHLIGHTS

• who: Andrew Berical from the Center forBoston University have published the paper: A multimodal iPSC platform for cystic fibrosis drug testing, in the Journal: NATURE COMMUNICATIONS NATURE COMMUNICATIONS
• what: The ability to derive an array of cell types from different organs affected by CF from iPSCs may facilitate studies focused on the multisystem nature of CF. The ambitious approaches aimed at treating or even curing individuals with class 1 variants include complex pharmacotherapy, gene-editing/delivery or cell-based therapies and will require ready access to cellular platforms.
• how: The authors hypothesize that . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.